Ibtrozi Drug Interactions: 112 Major, 406 Moderate
Ibtrozi (Taletrectinib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ibtrozi. Always confirm against the full prescribing information.
100 interactions
Abrocitinib
The serum concentration of Taletrectinib can be increased when it is combined with Abrocitinib.
Level 2 evidence
Acebutolol
The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Taletrectinib.
Level 1 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Taletrectinib.
Level 1 evidence
Acyclovir
The excretion of Acyclovir can be decreased when combined with Taletrectinib.
Level 2 evidence
Adenosine
The risk or severity of QTc prolongation can be increased when Adenosine is combined with Taletrectinib.
Level 1 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Taletrectinib.
Level 2 evidence
Albuterol
The risk or severity of QTc prolongation can be increased when Albuterol is combined with Taletrectinib.
Level 1 evidence
Alcaftadine
The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Taletrectinib.
Level 1 evidence
Alfuzosin
The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Taletrectinib.
Level 1 evidence
Amantadine
The risk or severity of QTc prolongation can be increased when Amantadine is combined with Taletrectinib.
Level 1 evidence
Ambrisentan
The serum concentration of Ambrisentan can be increased when it is combined with Taletrectinib.
Level 2 evidence
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Taletrectinib.
Level 1 evidence
Enter your NPI to unlock 18 major interactions for Ibtrozi
Ibtrozi (Taletrectinib) has 560 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ibtrozi (Taletrectinib) has 112 major, 406 moderate, and 42 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ibtrozi. Always confirm against the full prescribing information.